CVS Health denies coverage for breakthrough HIV drug, committing 'clear violation' of ACA
CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory factors."
August 22 2025 4:14 PM
Subscribe To
OUT MAGAZINE
OUT MAGAZINE
purpose 2
